Cost-effectiveness analysis of sofosbuvir-based regimens for chronic hepatitis C.
San Miguel R, Gimeno-Ballester V, Blázquez A, Mar J.
Gut. 2015; 64 (8): 1277-88. FI: 14.921 (Q1).
Conflicts of interest and need for transparency: in light of consensus on prescribing of new oral anticoagulants.
Rotaeche R, Osatzen.
Aten. Prim. 2015; 47: 545-546. FI: 0.953 (Q3).
Evaluation of health benefits and harms of the breast cancer screening programme in the Basque Country using discrete event simulation.
Arrospide A, Rue M, van Ravesteyn NT, Comas M, Larranaga N, Sarriugarte G, Mar J.
BMC Cancer. 2015; 15. FI: 3.362 (Q2).
